A detailed history of Hexagon Capital Partners LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 4,635 shares of BSX stock, worth $416,501. This represents 0.08% of its overall portfolio holdings.

Number of Shares
4,635
Previous 4,684 1.05%
Holding current value
$416,501
Previous $360,000 7.78%
% of portfolio
0.08%
Previous 0.08%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$72.96 - $84.0 $3,575 - $4,116
-49 Reduced 1.05%
4,635 $388,000
Q2 2024

Jul 12, 2024

SELL
$67.33 - $77.71 $13,129 - $15,153
-195 Reduced 4.0%
4,684 $360,000
Q1 2024

Apr 18, 2024

SELL
$57.6 - $68.62 $8,064 - $9,606
-140 Reduced 2.79%
4,879 $334,000
Q4 2023

Feb 05, 2024

BUY
$48.64 - $57.81 $6,615 - $7,862
136 Added 2.79%
5,019 $290,000
Q3 2023

Oct 23, 2023

SELL
$50.19 - $54.68 $1,505 - $1,640
-30 Reduced 0.61%
4,883 $257,000
Q2 2023

Jul 24, 2023

SELL
$49.72 - $54.64 $9,894 - $10,873
-199 Reduced 3.89%
4,913 $265,000
Q1 2023

Apr 24, 2023

SELL
$45.09 - $50.03 $20,290 - $22,513
-450 Reduced 8.09%
5,112 $255,000
Q4 2022

Jan 13, 2023

SELL
$39.56 - $47.22 $9,969 - $11,899
-252 Reduced 4.33%
5,562 $0
Q3 2022

Oct 17, 2022

SELL
$36.71 - $109.66 $41,482 - $123,915
-1,130 Reduced 16.27%
5,814 $225,000
Q2 2022

Jul 21, 2022

SELL
$35.24 - $47.1 $8,140 - $10,880
-231 Reduced 3.22%
6,944 $259,000
Q4 2021

Jan 27, 2022

SELL
$38.07 - $44.87 $5,710 - $6,730
-150 Reduced 2.05%
7,175 $305,000
Q3 2021

Nov 12, 2021

SELL
$41.23 - $45.88 $26,510 - $29,500
-643 Reduced 8.07%
7,325 $318,000
Q2 2021

Aug 11, 2021

SELL
$38.58 - $44.24 $259,990 - $298,133
-6,739 Reduced 45.82%
7,968 $341,000
Q1 2021

May 13, 2021

SELL
$35.27 - $39.67 $129,052 - $145,152
-3,659 Reduced 19.92%
14,707 $568,000
Q4 2020

Feb 05, 2021

BUY
$33.15 - $41.97 $31,492 - $39,871
950 Added 5.45%
18,366 $660,000
Q3 2020

Nov 10, 2020

BUY
$34.44 - $42.23 $599,807 - $735,477
17,416 New
17,416 $601,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Hexagon Capital Partners LLC Portfolio

Follow Hexagon Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.